Exact Sciences lauds pathway for Medicare coverage of early detection cancer tests
Madison-based Exact Sciences, a cancer diagnostics company, lauded the federal funding bill enacted last week for including a pathway for Medicare to cover multi-cancer early detection tests.
To access this content, you must purchase a Premium membership, or log in if you are a member.